Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
QuidelOrtho (QDEL)
NASDAQ:QDEL
Holding QDEL?
Track your performance easily
QDEL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$29.74 - $84.60
Previous Close$44.62
Volume651.21K
Average Volume (3M)1.17M
Market Cap
$3.00B
Enterprise Value$5.63B
Total Cash (Recent Filing)$107.00M
Total Debt (Recent Filing)$2.74B
Price to Earnings (P/E)―
Beta1.07
Next Earnings
Oct 30, 2024EPS Estimate
$0.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-27.79
Shares Outstanding67,235,394
10 Day Avg. Volume714,957
30 Day Avg. Volume1,168,518
Standard Deviation0.17
R-Squared0.00039
Alpha0.00788
Financial Highlights & Ratios
Price to Book (P/B)-7.60
Price to Sales (P/S)1.06
Price to Cash Flow (P/CF)-7.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.02
Enterprise Value/Gross Profit3.77
Enterprise Value/Ebitda69.73
Forecast
1Y Price Target
$46.33Price Target Upside4.51% Upside
Rating ConsensusHold
Number of Analyst Covering3
QuidelOrtho News
Bulls Say, Bears Say
Bulls Say
Cost SavingsPreviously announced $100 million in annualized cost savings are expected to be realized in the second half of 2024 and the first half of 2025.
Earnings1Q results came in above the Street expectations with total revenues of $711M.
Financial PerformanceThe company reported revenue of $711 million, which was higher than the consensus of $693 million.
Bears Say
GuidanceThe company suspended its 2024 guidance to allow the new CEO to assess the business.
Product LaunchQDEL formally withdrew its target of having Savanna RVP4 assay available for the 2024/2025 respiratory season.
Revenue ExpectationsThe company lowered its COVID revenue expectations from $225 million to $150 million year over year.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
QDEL FAQ
What was QuidelOrtho’s price range in the past 12 months?
QuidelOrtho lowest stock price was $29.73 and its highest was $84.60 in the past 12 months.
What is QuidelOrtho’s market cap?
Currently, no data Available
When is QuidelOrtho’s upcoming earnings report date?
QuidelOrtho’s upcoming earnings report date is Oct 30, 2024 which is in 60 days.
How were QuidelOrtho’s earnings last quarter?
QuidelOrtho released its earnings results on Jul 31, 2024. The company reported -$0.07 earnings per share for the quarter, beating the consensus estimate of -$0.233 by $0.163.
Is QuidelOrtho overvalued?
According to Wall Street analysts QuidelOrtho’s price is currently Undervalued.
Does QuidelOrtho pay dividends?
QuidelOrtho does not currently pay dividends.
What is QuidelOrtho’s EPS estimate?
QuidelOrtho’s EPS estimate is $0.31.
How many shares outstanding does QuidelOrtho have?
QuidelOrtho has 67,235,400 shares outstanding.
What happened to QuidelOrtho’s price movement after its last earnings report?
QuidelOrtho reported an EPS of -$0.07 in its last earnings report, beating expectations of -$0.233. Following the earnings report the stock price went up 6.897%.
Which hedge fund is a major shareholder of QuidelOrtho?
Among the largest hedge funds holding QuidelOrtho’s share is Maverick Capital ltd. It holds QuidelOrtho’s shares valued at 57M.
---
QuidelOrtho Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$46.33 (4.51% Upside)
$46.33 (4.51% Upside)
Blogger Sentiment
Bullish
QDEL Sentiment 60%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 116.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 1.5%
Last 30 Days ▲ 3.0%
Last 30 Days ▲ 3.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-42.13%
12-Months-Change
Fundamentals
Return on Equity
-45.48%
Trailing 12-Months
Asset Growth
-21.77%
Trailing 12-Months
Company Description
QuidelOrtho
Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA.
---
QDEL Company Deck
---
QDEL Earnings Call
Q2 2024
0:00 / 0:00
---
QDEL Stock 12 Month Forecast
Average Price Target
$46.33
▲(4.51% Upside)
Technical Analysis
Best Analysts Covering QDEL
1 Year
1 Year Success Rate
5/18 ratings generated profit
1 Year Average Return
-22.59%
assigned a buy rating 16 days ago
Copying Conor McNamara's trades and holding each position for 1 Year would result in 27.78% of your transactions generating a profit, with an average return of -22.59% per trade.
---